• Accueil >
  • Publications >
  • Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy

Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy

1 mai 2020European Journal of Cancer

DOI : 10.1016/j.ejca.2020.01.029

Auteurs

Andrea Ferrari, Johannes H.M. Merks, Julia C. Chisholm, Daniel Orbach, Bernadette Brennan, Soledad Gallego, Max M. van Noesel, Kieran McHugh, Rick R. van Rijn, Mark N. Gaze, Helene Martelli, Christophe Bergeron, Nadege Corradini, Veronique Minard-Colin, Gianni Bisogno, Birgit Geoerger, Hubert N. Caron, Gian Luca De Salvo, Michela Casanova